Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
p•••••••@radionetics.com
Personal email
•••••@•••••.com
Free to start · No credit card required
Current company Radionetics Oncology
Pharmaceutical Manufacturing · 48 employees · Founded 2021 · San Diego, California, United States
Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications and is poised to capitalize on the increasing demand for novel radiotherapeutics. Radionetics Oncology is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Global Investments and has entered into a strategic agreement with Eli Lilly. Radionetics is advancing a pipeline of first-in-class small molecule radioligands targeting G protein coupled receptors for the treatment of a broad range of cancers, including breast cancer, lung cancer, and other indications of high unmet need.